Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.470
+0.450 (14.90%)
At close: Aug 13, 2025, 4:00 PM
3.350
-0.120 (-3.46%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $149.97 million as of August 14, 2025. Its market cap has decreased by -63.23% in one year.
Market Cap
149.97M
Enterprise Value
-55.79M
1-Year Change
-63.23%
Ranking
Category
Stock Price
$3.47
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $149.97M, a decrease of -83.30%. That is a compound annual growth rate of -69.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 149.97M | -7.12% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |